Analyze Diet
Journal of veterinary internal medicine1998; 12(1); 36-41; doi: 10.1111/j.1939-1676.1998.tb00494.x

Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm.

Abstract: Of 17 foals born on a Thoroughbred breeding farm between March and April 1995, infection with equine herpesvirus type 1 (EHV-1) was associated with neonatal morbidity in 5 foals, 3 of which died or were euthanized. Morbidity and mortality were associated with pulmonary inflammation, and EHV-1 was identified in the lungs of the 3 foals that died. All neonatal EHV-1 infections occurred in foals of mares housed in the same pasture and barn. No other clinical manifestations of EHV-1 infection (e.g., abortion, neurologic disease, or respiratory disease) occurred during this outbreak. Three foals were treated with acyclovir (1 died, 2 survived), which may have influenced the clinical outcome in the surviving foals.
Publication Date: 1998-03-21 PubMed ID: 9503358DOI: 10.1111/j.1939-1676.1998.tb00494.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article illustrates the adverse effects of equine herpesvirus type 1 (EHV-1) infection on newborn thoroughbred foals, with 3 out of 5 infected foals losing their lives.

Study Background

  • The research revolves around the impact of equine herpesvirus type 1 (EHV-1) infection on newborn thoroughbred foals on a breeding farm.
  • The study began in March and ended in April 1995, observing a total of 17 newborn foals.
  • It aimed at understanding the influence of the virus on neonatal morbidity and death in foals in a breeding farm setting.

Results of the Research

  • Out of the 17 observed foals, five were found to be infected with EHV-1.
  • The morbidity in these infected foals was associated with pulmonary inflammation.
  • Three out of these five infected foals eventually died or were euthanized.
  • The EHV-1 virus was particularly identified in the lungs of the three foals that did not survive.
  • All infected foals were found to belong to mares that were housed in the same pasture and barn.

Other Relevant Findings

  • The research highlighted that during the outbreak, no other clinical effects of EHV-1 infection, such as abortion, respiratory disease, or neurological disease, were identified.
  • It was observed that three infected foals were treated with acyclovir, an antiviral medication. This treatment may have contributed to the survival of two out of these three foals.

Conclusion

  • The research paper underscores the severity of EHV-1 infections in neonatal thoroughbred foals, which resulted in increased morbidity and fatality in the observed population.
  • The presence of the virus in the lungs of the dead foals and absence of any other clinical symptoms suggest that EHV-1 majorly impacts the respiratory system of the infected foal.
  • The research also provides some insight towards a possible treatment method using acyclovir, which was found to have potentially improved survival outcomes in some of the treated foals.

Cite This Article

APA
Murray MJ, del Piero F, Jeffrey SC, Davis MS, Furr MO, Dubovi EJ, Mayo JA. (1998). Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm. J Vet Intern Med, 12(1), 36-41. https://doi.org/10.1111/j.1939-1676.1998.tb00494.x

Publication

ISSN: 0891-6640
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 12
Issue: 1
Pages: 36-41

Researcher Affiliations

Murray, M J
  • Marion duPont Scott Equine Medical Center, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute, Leesburg, USA. mjmurray@vt.edu
del Piero, F
    Jeffrey, S C
      Davis, M S
        Furr, M O
          Dubovi, E J
            Mayo, J A

              MeSH Terms

              • Animals
              • Animals, Newborn
              • Antibodies, Monoclonal / immunology
              • Antibodies, Viral / blood
              • Disease Outbreaks / veterinary
              • Female
              • Fluorescent Antibody Technique, Indirect / veterinary
              • Herpesviridae Infections / epidemiology
              • Herpesviridae Infections / pathology
              • Herpesviridae Infections / veterinary
              • Herpesvirus 1, Equid / immunology
              • Herpesvirus 1, Equid / isolation & purification
              • Horse Diseases / epidemiology
              • Horse Diseases / pathology
              • Horse Diseases / virology
              • Horses
              • Lung / pathology
              • Lung / virology
              • Mice

              Citations

              This article has been cited 4 times.
              1. Thieulent CJ, Sutton G, Toquet MP, Fremaux S, Hue E, Fortier C, Pléau A, Deslis A, Abrioux S, Guitton E, Pronost S, Paillot R. Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C(2254) Variant. Pathogens 2022 May 4;11(5).
                doi: 10.3390/pathogens11050539pubmed: 35631060google scholar: lookup
              2. Maxwell LK, Bentz BG, Gilliam LL, Ritchey JW, Pusterla N, Eberle R, Holbrook TC, McFarlane D, Rezabek GB, Meinkoth J, Whitfield C, Goad CL, Allen GP. Efficacy of the early administration of valacyclovir hydrochloride for the treatment of neuropathogenic equine herpesvirus type-1 infection in horses. Am J Vet Res 2017 Oct;78(10):1126-1139.
                doi: 10.2460/ajvr.78.10.1126pubmed: 28945127google scholar: lookup
              3. Garré B, Shebany K, Gryspeerdt A, Baert K, van der Meulen K, Nauwynck H, Deprez P, De Backer P, Croubels S. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses. Antimicrob Agents Chemother 2007 Dec;51(12):4308-14.
                doi: 10.1128/AAC.00116-07pubmed: 17846132google scholar: lookup
              4. Normand C, Thieulent CJ, Fortier C, Sutton G, Senamaud-Beaufort C, Jourdren L, Blugeon C, Vidalain PO, Pronost S, Hue ES. A Screening Study Identified Decitabine as an Inhibitor of Equid Herpesvirus 4 That Enhances the Innate Antiviral Response. Viruses 2024 May 8;16(5).
                doi: 10.3390/v16050746pubmed: 38793627google scholar: lookup